Vapocoolant Spray Used Prior to Intravenous (IV) Insertions

Completed · Phase 4

Conditions studied: Pain

In brief

The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.

Key facts

Study ID

NCT03054740

Run by

Aultman Health Foundation

People needed

30

Starts

2017-02-27

Expected to finish

2017-04-28

Last updated by the study team

2018-10-03

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Any outpatient ordered to undergo a Nuclear Medicine Stress Test and is required to have IV access for injection of Radiopharmaceuticals

You may not qualify if…

• If it is the first time the patient has had an intravenous catheter inserted
• Any patient who is or may be pregnant
• Any patient who is breast-feeding
• Any patient who has taken a narcotic, sedative and/or anti-anxiety medication within 8 hours of intervention time.
• Any patient who has a known diagnosis of Raynaud's Syndrome or Carpal Tunnel Syndrome.
• Any patient who has an allergy or hypersensitivity to Ethyl Chloride.
• Any patient under the age of 18 and/or any patient over the age of 85
• Any patient who is illiterate
• Any patient who is non-English speaking
• Any patient with prior experience with a vapocoolant spray.

Where it is running

• Aultman Health Foundation — Canton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.